Modulation of Cell Proliferation and Hypertrophy by Gangliosides in Cultured Human Glomerular Mesangial Cells

  • Lee Seoul (Department of Pharmacology, Wonkwang University School of Medicine) ;
  • Ahn Seon Ho (Division of Nephrology, Department of Internal Medicine, Wonkwang University School of Medicine) ;
  • Baek Seung Hoon (Division of Nephrology, Department of Internal Medicine, Wonkwang University School of Medicine) ;
  • Song Ju Hung (Division of Nephrology, Department of Internal Medicine, Wonkwang University School of Medicine) ;
  • Choo Young Kug (Division of Biological Science, College of Natural Science, Wonkwang University) ;
  • Kwon Oh Deog (College of Veterinary Medicine, Kyungpook National University) ;
  • Choi Bong Kyu (Department of Pharmacology, Wonkwang University School of Medicine) ;
  • Jung Kyu Yong (Department of Pharmacology, Wonkwang University School of Medicine)
  • Published : 2005.08.01

Abstract

Glomerular mesangial cells (GMCs) in diverse renal diseases undergo cell proliferation and/or hypertrophy, and gangliosides have been reported to play an important role in modulating cell structure and function. This study compared the effects of transforming growth $factor-\beta\; (TGF­\beta1)$ and the effects of the application of exogenous gangliosides on GMCs and investigated whether the application of exogenous gangliosides regulated cellular proliferation and hypertrophy. Human GMCs were cultured with exogenous gangliosides and $TGF-\beta1$ in a media containing $10\%$ fetal bovine serum and in a media without the fetal bovine serum. Exogenous gangliosides biphasically changed the proliferation of human GMCs (0.1-1.0 mg/mL). A low concentration (0.1 mg/mL) of gangliosides mainly increased the number of human GMCs, whereas cellular proliferation was significantly reduced by raising the concentration of exogenous gangliosides. $TGF-\beta1$ greatly reduced the number of human GMCs in a concentration­dependent manner (1-10 ng/mL). Serum deprivation accelerated the gangliosides- and $TGF­\beta1-induced$ inhibition of mesangial cell proliferation to a greater extent. Gangliosides (1.0 mg/ mL) and $TGF-\beta1$ (10 ng/mL) both caused a significant increase in the incorporation of $[^3H]leucine$ per cell in the serum-deprived condition, whereas it was completely reversed in serum­supplemented condition. Similar results to the $[^3H]leucine$ incorporation were also observed in the changes in cell size measured by flow cytometric analysis. These results show that exogenous gangliosides modulate cell proliferation and hypertrophy in cultured human GMCs, and these cellular responses were regulated differently based on whether the media contained serum or not. Results from the present study raise new possibilities about the potential involvement of gangliosides in the development of mesangial cell proliferation and hypertrophy.

Keywords

References

  1. Border, W. A. and Noble, N. A., TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int., 51, 1388-1396 (1997) https://doi.org/10.1038/ki.1997.190
  2. Dubus, I., Vendrely, B., Christophe, I., Labouyrie, J. P., Delmas, Y., Bonnet, J., and Combe, C., Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney Int., 62, 857-867 (2002) https://doi.org/10.1046/j.1523-1755.2002.00514.x
  3. Floege, J., Johnson, R. J., and Couser, W. G., Mesangial cells in the pathogenesis of progressive glomerular disease in animal model. Clin. Invest., 70, 857-864 (1992)
  4. Fujino, T., Yuhki, K., Yamada, T., Hara, A., Takahata, O., Okada, Y., Xiao, C. Y., Ma, H., Karibe, H., Iwashima, Y., Fukuzawa, J., Hasebe, N., Kikuchi, K., Narumiya, S., and Ushikubi, F., Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells. Br. J. Pharmacol., 136, 530-539 (2002) https://doi.org/10.1038/sj.bjp.0704749
  5. Hakomori, S., Bifunctional role of glycosphingolipids: modulators for transmembrane signaling and mediators for cellular interactions. J. Biol. Chem., 265, 18713-18716 (1990)
  6. Hakomori, S. and Igarashi, Y., Functional role of glycosphingolipids in cell recognition and signaling. J. Biochem., 118, 1091-1103 (1995) https://doi.org/10.1093/oxfordjournals.jbchem.a124992
  7. Harth, S., Dreyfus, H., Urban, P. F., and Mandel, P., Direct thinlayer chromatography of gangliosides of total lipid extract. Anal. Biochem., 86, 543-551 (1978) https://doi.org/10.1016/0003-2697(78)90781-9
  8. Kagami, S., Kondo, S., Urushihara, M., Loster, K., Reutter, W., Saijo, T., Kitamura, A., Kobayashi, S., and Kuroda, Y., Overexpression of a1b1 integrin directly affects rat mesangial cell behavior. Kidney Int., 58, 1088-1097 (2000) https://doi.org/10.1046/j.1523-1755.2000.00266.x
  9. Kwak, D. H., Rho, Y. I., Kwon, O. D., Ahn, S. H., Song, J. H., Choo, Y. K., Kim, S. J., Choi, B. K., and Jung, K. Y., Decrease of ganglioside GM3 in streptozotocin-induced diabetic glomeruli of rats. Life Sci., 72, 1997-2006 (2003) https://doi.org/10.1016/S0024-3205(03)00090-0
  10. Mahadevan, P., Larkins, R. G., Fraser, J. R., and Dunlop, M. E., Effects of prostaglandin $E_2$ and hyaluronan on mesangial cell proliferation: a potential contribution to glomerular hypercellularity in diabetes. Diabetes, 45, 44-50 (1996) https://doi.org/10.2337/diabetes.45.1.44
  11. Masson, E., Wiernsperger, N., Lagarde, M., and El Bawab, S., Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. Biochem. J., 388, 537-544 (2005) https://doi.org/10.1042/BJ20041506
  12. Mirkin, B. L., Clark, S. H., and Zhang, C., Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1a, and GT1b. Cell Prolif., 35, 105-115 (2002) https://doi.org/10.1046/j.1365-2184.2002.00228.x
  13. Morales, A., Colell, A., Mari, M., Garcia-Ruiz, C., and Fernandez-Checa, J. C., Glycosphingolipids and mitochondria: Role in apoptosis and disease. Glycoconj. J., 20, 579-588 (2004) https://doi.org/10.1023/B:GLYC.0000043294.62504.2c
  14. Rho, Y. I., Kwak, D. H., Lee, S., Ahn, S. H., Baek, S. H., Song, J. H., Choo, Y. K., Choi, B. K., and Jung, K. Y., Mechanism for the negative regulation of cell proliferation bt ganglioside GM3 in high glucose-treated glomerular mesangial cells. Life Sci., 75, 51-62 (2004) https://doi.org/10.1016/j.lfs.2003.11.021
  15. Schwarzmann, G., Uptake and metabolism of exogenous glycosphingolipids by cultured cells. Semin. Cell Dev. Biol., 12, 163-171 (2001) https://doi.org/10.1006/scdb.2000.0233
  16. Shayman, J. A. and Radin, N. S., Structure and function of renal glycosphingolipids. Am. J. Physiol., 260, F291-F302 (1991)
  17. Simons, M., Friedrichson, T., Schulz, J. B., Pitto, M., Masserini, M., and Kurzchalia, T. V., Exogenous administration of gangliosides displaces GPI-anchored proteins from lipid microdomains in living cells. Mol. Biol. Cell, 10, 3187-3196 (1999) https://doi.org/10.1091/mbc.10.10.3187
  18. Stephenson, L. A., Haney, L. B., Hussaini, I. M., Karns, L. R., and Glass II, W. F., Regulation of smooth muscle ${\alpha}$-actin expression and hypertrophy in cultured mesangial cells. Kidney Int., 54, 1175-1187 (1998) https://doi.org/10.1046/j.1523-1755.1998.00101.x
  19. Svennerholm, L., Quantitative estimation of sialic acid. II A colorimetric resorcinol-hydrochloride method. Biochim. Biophys. Acta, 4, 604-611 (1957)
  20. Tsuboi, N., Utsunomiya, Y., Kawamura, T., Kikuchi, T., Hosoya, T., Ohno, T., and Yamada, H., Shedding of growthsuppressive gangliosides from glomerular mesangial cells and undergoing apoptosis. Kidney Int., 63, 936-946 (2003) https://doi.org/10.1046/j.1523-1755.2003.00817.x
  21. Wolf, G., Cell cycle regulation in diabetic nephropathy. Kidney Int., 77, S59-S66 (2000)
  22. Wolf, G. and Neilson, E. G., Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am. J. Physiol., 259, F768-F777 (1990)
  23. Yamagishi, K., Mishima, K., Ohgami, Y., Iwasaki, K., Jimbo, M., Masuda, H., Igarashi, Y., Inokuchi, J., and Fujiwara, M., A synthetic ceramide analog ameliorates spatial cognition deficit and stimulates biosynthesis of brain gangliosides in rats with cerebral ischemia. Eur. J. Pharmacol., 462, 53-60 (2003) https://doi.org/10.1016/S0014-2999(03)01325-6
  24. Young, B. A., Johnson, R. J., Alpers, C. A., Eng, E., Gordon, K., Floege, J., and Couser, W. G., Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int., 47, 935- 944 (1995) https://doi.org/10.1038/ki.1995.139